OPRX - Earnings call transcript Q1 2022

Due to licensing restrictions, you must log in to view earnings call transcripts.

Operator

Greetings. Welcome to OptimizeRx Corporation's First Quarter 2022 Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] Please note, this conference is being recorded. the to turn Febbo. now will conference Will over I Thank you.

You begin. may

William Febbo

fiscal afternoon, Hi, first you new operator. you, and call everyone. the our Thank for Good thank OptimizeRx for of year. joining

but ahead stay of mission building more In on that developing the the have the life-impacting and operating of informed help to enabling by doctors Our health community and clients technology Healthcare's therapies. we a at engagement care a care, not remains our patients empowered connectivity point of new evolving greater. digital rapidly people digital transformation, serving stay privilege also solutions pharma need start our at strategy, executing be and time could and when

provider choice connection clients strong we especially technology looking very large for their when are to our epicenter we have for is powerful, our technology care as market-leading enablement. solutions built a delivery Our patients care married of and have a platform of digital the care who markets. network. and with HCP valuable end doctors The network The and digital point incredibly connectivity health that clients, to to is pragmatic are

more significant which incremental our us revenue opportunities. the drive conversations more and network at clients the partners, seat a seeing are of care We initiatives strategic expand could that and at communication grant beyond with point and table for

markets have Before moving tumultuous. the on, I been understand to want we everyone know

in some investor an myself, believe high-level into As business delve I important it's the fundamentals. to

on I'm excited bullish before. business position our than why and So ever our more everyone understands and

pharma the from comes business largest our of XX% nearly off, manufacturers. First XX

financial pandemic. remarkably strong in today position remain performed the and well throughout clients have Our

by its commercial innovate while transforming dismantling and significant digital solutions. is and continuing reallocating to operating In towards addition, resources legacy pharma infrastructure grow model

resilience to in highlighted and this evidence making economic bellwethers months for You and their their see top in to don't this we've companies. members move On of many that, industry's this recent to new is win releases investor C-suite of very their for of presentations have priority an a the added have to as business even strategic our clear in hard downturn. look need positioned press

sub-$X We have outpaced have for companies that flow This year-over-year error a with revenue cash us profitable for positions meaningful examining and at EBITDA and objective billion discipline a generating adjusted to before. is opportunities on our and and sheet in market has it a operating less trailing dilution M&A We with targets. other when accretive valuations XX-month particularly balance our digital multiple capitalize steadfast targets pristine shareholder are than strategic significantly growth. health, caps better rare remain

significant are maintaining ensure being extraordinarily of our while in consistent the a with M&A life scalability. long-term for science selective that to industry, our leading order vision partner stays tech-enabled strategy We

we adoption Finally, of most cycles, for stages successful early like are very innovation S-curve pharmas the are the point transition. following trajectory [ph] the and disruptive in inflection

We strategy. have building to approach higher land-and-expand solutions our support our of consistent value been in

we in execute Our capture objectives. will provide as our more to and Ed well KPIs, detail, continue which transparency discuss this will

sheet a coupled consisted first a labor initiation Our improved manufacturer. highlights in of from the and serve one for pharma this macro and is operate and brand and that market, chains us of this XX a When to program us nimbly act strategically biologic date, quarter health clients. to providers launch impacting patients, top opportunity visibility continue XXXX. supply to program of infrastructure, our our therapy business our affords positioning are to rates with the expansive This resulting strong anti-inflammatory many our was well continues from scalable the as to most the the industries. headwinds and growth care of outside enterprise Therefore, current new maintain trajectory we which beyond interest strong balance

initiation patient levels their proud addressing with be as the key they client assess our to challenges clients our launch. been strategies high to are how for commercialization in partner a We specialty digital in for advance involved at have the drug more therapy personally I process.

for our where and propelled care. have targeted building seeking and made. sequential the In the limitations the our The digital of other mega took a partner was over clients. growth. XXXX, industry's with simultaneously are imperative, apart network have complex science growing will have scalable that physicians we in consistently elegant pharma can by the reach these of fiscal we to to care. perspective, of maximize is our medical continued manufacturers. access While and largest and billion supporting constraints patients completely partnerships above currently. to experience investments top XX from manufacturers traditional beneficial current XX% a $X design support momentum of sustaining continue The billion foundation us while direct we commercial to From COVID-XX care ability trends, carrying COVID-XX $XX from These sites being spend of our our having on of decisions created ourselves their and commercial now activities strengthen capitalize investments shut of solutions, as which approximately the XXXX like ensures engagement care made critical the increase technology physician point many order to develop estimated are our the of down platform premier at at patients, platform and as part technologies continue for with technology years, set events to position laid clients allows life to aware uninterrupted are to pandemic our to point Pharma care, connected as toolkit care It point for patients. to well

solutions. from we strategy to brands brands, also as of enterprise win key to upcoming Our remains land our clients' revenue unlocking expand more can well our and generation as as that continue benefit

three at to the our continues team offering right strategic execute having ahead, to on increasing enhancing clients. the As which focused and digital our remaining operating and enablement helm our solutions basic around capabilities value are forge of initiatives, we the to our growth, center strategy tenets

continue platform our keen science we which more us cutting-edge with capabilities acquisition completion our focus our also the The on of markets. and And are algorithms intelligence well We behind solutions. to key for data-centric to us a of excited enable time markets, on simplify positions order access the artificial enhance proprietary emphasis of enhance our note patients. our to therapy the key greater EvinceMed,, speaking as markets care enabling providers, further reach to specialty This organic of to solutions to medications serves and process for asset our purchase in medications strategic core prescribing trajectory. growth faster our point-of-care with such for expands health specialty to

integration by health specialty for drug and are care to the affordability We process XX% and of automating providers improving eligibility EvinceMed, market. manual will of across OptimizeRx intelligent millions advance the our our increasing stay simplifying patients Full patients. over determine connects therapy, prescribing steps help while and of our assets also to currently U.S. ability and addressable margins network, products technology which on start

factor those health early be shown intervention capability science can the in patient mentioned positive deciding valuable whether particularly outcome. a companies, As life this have specialty where a will with to to brands is be prior,

prescription which represent and While billion which U.S., total we've market. X% patient of prescription pharmacy heavily exposed nearly only barriers to use of XXXX, unique the spend, roughly focus for and chosen medications account is in the was specialty The roughly specialty of total process. XX% the to on volume drugs cost $XX they this why in have the increasing access

access Although positioned staff and services affordability with to survey manufacturing assist provide well process, of enrollment. found adherence, such patients to their and Doctors needed patients medication were programs. program recent a support programs in prescription that aware XX% are of much aid

a However, point resulting this the for in time treatment. in them, currently significant often patient's to process delays is pain

for process We to are stock. and their diligently working the doctors simplify this

accelerated to in enterprise continue specialty and seeing are medications, As oncology we we increased our for growth an demand solutions. see

physicians for early AI-driven the solution, to from using The strategic niche, which to is clients. with Discussions across assists orphan We It nature requiring and combined demand senior its our opportunities in this for predicting makers. for rare patient non-adherence integration indicators with therapies. with are them in clients for find their developed of nature and engagement network evidence in specific seeing hard-to-find being in also predictive are therapies growing decision real-world is solution, increase and reaching executives elevate qualify communicate continue may our or also illuminating populations, patients There our diseases. challenges clients with a patients. growing whose game-changing tool affordability of

industry at to KPIs, back white Looking XX-month continue we makes only space. sense that it capture the

as employee optimize revenue As per while our brands, we built we clients' been also improving has per are deepen more its our manufacturer, revenue full-time across relationship generating platform scalability. top to our

both at quantifiable remains the and are Client XX:X clients, our For ROI compelling. end spend. against results their high

the turn the want Ford. is citizen, I mission to metrics capitalism first Compliance adopted will good now led long-term Chief with Officer; that, our is demands Forum before call broader for the with a OptimizeRx stakeholder and who financial us Stelmakh, pass our I Ed? to release champion. call to over value and our to of and as creation the and by measure, for Counsel Odence a I'd people effort This report. environmental, our corporate governance COO, Now Economic sustainable benchmark the demonstrate to The and goals mantra that General CFO the And social our our Ed has of and Marion to We've World the walk Ed, improve, planet. organization mention aligned to through commitment QX. and details like of embraces entire to continues

Ed Stelmakh

everyone. and Will, afternoon, good Thanks,

XXXX. press may our with viewing ended first release downloaded Relations of As a from our A be calls, the for quarter results with copy all and Investor issued is section March was the of XX, website. our available

through will our can which days. XX-Q, forthcoming filed information obtained coming be Additional the in be

the period. Turning financial to results our for

the the in from access in Our million, an and over period was quarter increase resulted revenue $XX.X revenue increased of $X.X our in XX% from million the The messaging growth same sales solutions. XXXX. for

and increased quarter XX, Our XX, XX% from ended XXXX. the March XXXX, gross quarter margin in March in XX% ended

more a to increase network Generally, of a flowing there year an compared in solution when ago. with activity of has mix. channels As economics favorable been result through percentage and the partner

to $XX are come calls million XX% in between revenue which performance the and for in between $XX of reiterating gross and and margin guidance, we our the XX%. million for first year our XXXX, Given quarter

per during same non-GAAP basis, net our net for share to from first million to increase future or of $X.X $X.XX net team Our or in $X.XX ended per $X.X quarter of is a infrastructure enable a future for the vosof$X.X expense. operating for as to Overall, XX,XXX On expenses primarily to meet investment the the or technology and We increase ago increase of period in share $X.X a increased million the same non-cash March the expense due and to pg year-over-year XXXX in XX, share significant XXXX. the diluted net growth. growth. a XXXX, ended compared OptimizeRx $X.XX quarter X in million the to support tied loss income investments and during $X.X the $X.XX non-GAAP diluted to the resulted first This basic period. the million months million diluted and and our was per loss from as and outstanding, expansion had people basic XXXX, compensation fully compared XXX,XXX of basic net stage months per based XX, outstanding three was of fully in March year fully to XXXX. loss of

to to March and funds million of $XX.X to revenue equivalents compared cash turning and further XX, XXXX, our XXXX. these totaled December on plan million use business balance XX, We to Cash Now sheet. accelerate growth. our expand $XX

can to I'd quantifiable the to story past provides like as continue transparency, used which that our as to introduced to and that KPIs as we grows be Now turn business February, well this communicate matures. our company's metrics

now in the primarily result XX signing XXXX adding XX XX per our again supporting we the in through on focus XX spend. the was are revenue the to average with which which and customers the despite commercial continue the share the two last of more new lion's additional of $X.X [indiscernible] brands relationship ground top manufacturer with represents top largest comprehensive here Growth industry's still to life grew pharma Our us. larger cycle world, and of million deals as gain in months, over XX% year-over-year companies early by

first value our ability as in addition, quarter of In as well our clients, net XXXX. of solutions demand for revenue our the to growing create for XXX% is for retention tangible rate our reflected

for metric capability represents for team XXXX, a significant our improvement in continues an which quarter a growth ever an industry-leading employee to model first environment. year-over-year was XX% operating ability Our macro $XXX,XXX already full-time evolving built leverageable we to in testament at nimbly with act demonstrate the on what revenues of per have and the to

We to our with ensure KPIs the Will? report like call on open on Will. shareholders. And these will now a the continue year back transparent I throughout to with that, basis communications turn to regular to over and would

William Febbo

Thanks, Ed.

access that worth we care strategic road takeaways confident mentioning the way take put motion at tailwinds affordability advantage and care. is have again. are into adherence of right of that the right addressing driving map these are We patient to health point are The

going continue pandemic astoundingly bedding, as First in they is our the come trajectory science yes, will fitting dismantle of client continue in transformative particularly from adapt and to operating products, specialty the base, COVID-XX infrastructure, through also shape. end model answer The that advances their is off to back changes pharma their commercial the the of are function. to new good They technology. legacy and

for Just like at over companies OptimizeRx. last top of a This tailwind the companies look headlines few the XX pharma months. is the

industry the our balance lower and and flow a very for in potential us with capitalize infrastructure. our being our cash financials significant stays acquisition life sheet, been operating with on of by top ability multiples Second, a and This the M&A puts targets. vision profitable in competition to leveraging We've tech-enabled positive ability for to long-term our ensuring themselves our solution P&L. gives scale that percentile for existing pristine consistent science a of strategy speak selective us careful with

still typically are we cycle trajectory. Third, digital innovations early in adoption all the the as follow S-curve

consistent value approach higher been in support our build land to We strategies. solutions to and our have expand

that well to continue level I call OptimizeRx capture thank continue want of to would and to be strategy. KPIs today. we success provide particularly transparency I possible on without will the on to employees, everyone for our thank stakeholders the Our as this our us to want right and execute growth you. joining not

marathon, are continuously will is to investors our You clients, they this [ph] helping This stakeholders, our a maximum not year. achieve and and the successes a that deliver value we all sprint.

call. in our We onward. Operator? you So the one hands, everyone. as team say we all join having forward look and to Thanks, us for next

Operator

Please from [Operator with Instructions] William first Ryan Our is you. Thank Daniels question Blair. proceed.

Ryan Daniels

the to to regards a one given expressed versus for the for more start pipeline in high normalcy, maybe as you're the as trade and of pharma just the doesn't again, taking companies anything given It to nature and or to that year. shows, go continuing questions really things rate we conversion ROI? is to of year. Yeah, budgets return dedicating if relates on guys. to start Will, strong Thanks sales reopening digital. digital and pace through Or the appear a the you. towards congrats But I'm strong be the curious you case the the seeing confidence it

William Febbo

year Ryan, really Yeah. No, happy the way thanks. started. the with Hey,

disruption of returning right? they traditional the are last of sort we to a seen to at all don't year, - and from they infrastructure that marketing, methods. not expect have So And be happening started idea headwind. We really

going a of I the matter ships say don't they do is happen it As complement fast. and fact, should - shifts will big big there's what still through industry digitally.

funds much as as and approach. a the have much they while pharma, verify want, they're they very So can and allocate test

had but ones the a we've still a really test it starting that's are long And those start those that at starting probably flowing it. And was tenure, their it well. clients Obviously, to and such are seen good higher year. new measure certainly increasing spend to so what level, is we've for and

approach in better, want no just So it to good our has wants evoked work tell not do your to going And best that's way. because always methods about try traditional enable some - you're if them - be together. something, you It to do the two some client to not to getting conversations if to not it. how the

lot way nothing So we've yeah, the in no, had of yet. a And conversations.

Ryan Daniels

a bit, this in seen have on a digital curious if but to Has wanted have not I'm public multiple look out faced premium more 'XX? into would that just companies hit then from little in you reversed opening have you there is you, then pressure. particular, a that reset Or for a been or ton of head we they the and obviously, And has but of cash health been the at a as up markets growth a there or late, to the expensive basis, assets earnings. regards private all pipeline have the not to the you such relative their that little Perfect. kind turmoil, lot under revenue on reset yet Okay. of what yet? maybe of bit markets, that too

William Febbo

say performing Yeah. to I public us it your right it so especially it's well. And like it, feel mean in frustrating, awful people when don't the and is feels business away. side

delay. ultimately, the most private got the for money On side, But markets is from you've that where comes transactions. capital

would So say there's to be going opportunity the really I good year. through

world do right SPAC I been been as now. will be pushed. a desired, all not always liquidity the think of right as us I these us again, just people through But to because anything I think us. significant be help going not be of and think the of market I and year, really opportunity. rushing the rush. potential assets a super we help pressure But we're kind it going tumultuous we're said, So will buyer - into think to there's just was to But for it's is markets and selective, general. right? adjustments, there's teams out, not going have in and taken yes, obviously, But the IPOs the And how have

Ryan Daniels

offline. Okay. And last Very the take and then question I have, helpful. I'll rest

Just investments on any you of a year. thoughts on the updated I through some know year had cadence heavy last year. talent of maybe bringing the the pretty

Some model sales any the or things it year? into of I'll a may and just for Thanks. there. we consider grow that. you or But of the rest cadence about that's bit, the little update leave investment cadence for either should abated really

William Febbo

tools of invest invest aberrations are willing about really Thanks, one-off with we Ryan. If in which talked they know and No bring past. the connect to what innovative leaning and We're we've them return. to from in our partners contract, that significant those situations letting care the a we're already can together. patients. frankly doctors can't a And is point or nice for to long-term generating to

of So grow year very get with to closer partnerships there. and sure the no our client drama another the just solutions are ample. of relevant really the reach head make strategic our sort We're down business, to and is

Ryan Daniels

Perfect. Thank you, again.

William Febbo

Thank you.

Operator

proceed. next Dodge RBC Sean question from Capital Our is Please Markets. from

Sean Dodge

afternoon Good strong add from in I'll decisions start. the mentioned org congratulations interest and channels moving and increased chart. the my pharma up Thanks. higher the strategic digital in Will, on you the

what with sharing mechanism continues, your And models begin give that offerings? kind terms value you with the or open does Does them? subscription-like up of to possibilities move of a or creating over changing that cover contract for of more to time? how in does to capturing in you potentially that more you're of As like you create possibilities this kind

William Febbo

out the seeing to pharma. is, do And that know having for really subscription is to we getting right? challenge. it and that We able meet word to say some at have No, Sean. we've or it know say allows into. understand Can our that budget you're gets they're glad been not when I and seeing liked a next us does of that's But They And scalable? them and their can table challenges, those something risk The us they quickly. we listening challenges wouldn't solutions model that's moves we it? towards Thanks, think pretty can prefer what throughout really I what they largely handle them. measure actually understand to their know think share kind we Yeah. really I'm And really it - how to show can. that But it it. question

their think suite right press partner is have partner we And releases to a are really I just seen key a of I client base you've sure we've care that's - and more technology just probably at reliable now make understands solutions. long-term think on really of point great the and we're industry. focused getting really

at to other So not of unfortunately, you growth SaaS-like gotten when that have you for and get very years. a very sticky, lot of lot industries, but not there, the companies a strategic, - look subscription, it's be if have it's you

Sean Dodge

specifically, of Okay. G&A, any the the But pretty how on reiterated puts your forward? on going Great. rest understand And over just being for I'm then flat gross there may of unfolding margins little But have the on the course bit We're the year. think more year on investing margins, G&A you trying the to can for need to dollars Is touched and those you previous. think to for thinking EBITDA we about here? you year. just targets and takes a about do kind of on

William Febbo

it - Yeah we're and I'll company. the then look, But we're I'll early to an in is start reality Ed. stage hand

to think absolutely we if So need we will. invest, we

got got TAM, we the factor. to invest got talked do to profitable. strong the it. unbelievable to an We've show like think company to there But the team. But it. about the the market Certainly, before. I business, We've more? to And need ability awareness we've up. a cash. the now, it get like And wants the to pace grow we've of Right that's is factor continue we it's the part all there. we have is, We And be all - real

buy It's business. this into very don't way hard. your You

build really into your it. way You

money, ahead get all it to as going would benefit we And you on as you're so means quickly but the it. necessarily getting lose want hiring doesn't just

to add So we're going on else that? to anything Ed, keep approach. that

Ed Stelmakh

mean, we [ph] I think business. I'll you I say, affordability well. run an covered just it

the year, we see for when according of this. the and invest I to grows, we business said rest the As

of we're the too ahead to far get trying numbers. So not

I mind So that certainly faster, operating can which expenses go top just think that modeling to keep too we - as in line. allow not you faster you're out, roll than will much

Sean Dodge

That's Okay. you. very Thank helpful.

Ed Stelmakh

problem. No

Operator

Our Riley proceed. B. with is question Securities. from next Mark Please Wiesenberger

Mark Wiesenberger

company taking good done talk the contracted? Thanks, afternoon. the heavy $XX you XXXX questions. could what to a you if the to has lifting kind the hit of Appreciate percentage $XX lot million that revenue is about currently guide release, million In that objectives. noted you of Wondering of your

William Febbo

we've of very have, talked as are Well, about a good these renewal A of through in which against. the very visibility last have lot renewals quarters, we midyear, out. obviously, months kind X we rate high

percentage So first enough But stands I'd yeah, want year it's guidance, I very I feel in feel be about out our pulling on that the the still to give a range. think own. air. don't it with of we its you confident to of kind confident being because that

Mark Wiesenberger

those can maybe of appreciate if understand you Understood. Wondering could new on a update through how of us so backfill the evolved few year. I KPIs. Helpful. for kind they last the we

William Febbo

Andy, And take want Sure. that? to you

Andrew D’Silva

Yes, sure Yes.

you basically, year to forward. as obviously, two those sense KPIs last last for the year. But quarters we'll of So moves give of disclose kind a

thereabouts probably for can X.X and … the million of number for XXXX. QX one you QX of XXXX use get We'll about or to So X.X%

Mark Wiesenberger

Sure.

of kind that other of gain far with a is there started relationship? partners might you How Could of new integration? year, talk think about kind as And have are of channel similar year. channel opportunities kind with partner last well? early the towards end efficiencies other new you the of to kind along this I

William Febbo

Yeah, Mark.

partner are conference yesterday and I a was Asembia, in at is we several and of out strong matter So running day the up yes, Vegas and with and going partner that which with that [indiscernible] others. most

I you was team little. the meeting and care, having think very done, done care an actually paid area our has and culture in going right reach mean that go talked off? client, viewed innovator channels. really yes, good job them an And is on I'm we got that really to were and Even takes approach, longer, really which so channels very omnichannel only has And get I And about, at where what much just help front, us thing. say, exploring building is as got there of progress great we're that's multiple it and multiple we've too. trust we're an our I such that credibility that do but every then well point we've a as and if have means additional we've boy, little helper, want. like the can received, to care, we've we for just obviously a seen

issues the team do We solid. better of very very, and And give the all. not much that. for So credit I think reach of a are have team year-over-year, at relationships I quality the lot the whole

Mark Wiesenberger

XX pharma spend. across just if that in the average of place And Got XX drivers continued Wondering you. one kind it. pharma how I to see you could little are of that? many the appreciate And it. in then just final top bit programs unpack maybe Thank a for primary me. partners? top a nice It's then increase the

William Febbo

keep start mind QX have bit Ed, little I number in can but maybe the But to at the early in more. right? have it unpacking it's looking I'll then hand talk and it to know in - specifics is year, a you don't you Ed. So if to Okay. of you the that,

Ed Stelmakh

the same in we it's the mean I dynamics had Yeah. past.

handful brands specific getting that's to XX get continue XX, bigger a individual we expand numbers, those So typically [ph] accounts accounts. and a drove kind without on to And there's I we for number just of mean to of share to XXXX. our that manage land basically, getting as QX wallet what execute of

expand. continue accounts. to And continue continue grow, to So as we we these we'll that mature hopefully, see

Mark Wiesenberger

very you the Congrats Thank much. quarter. Okay. on

William Febbo

Sure.

Operator

Our Capital from with Max Michaelis next Markets. proceed. Lake question Please Street is

Max Michaelis

top for me. But know I are line How there in guidance your First, guys guys the somewhat are $XX million. I guys. now know XXXX doing? EBITDA? if of at million $XX you comfortable like one million X.X to right current Hey, consensus focus and on you adjusted question QX. for with on like just just reiterated I'd XX.X the to to would out you and then

Ed Stelmakh

Eric Yes. is our annual see to hi, Good to year quarterly. - comment we you, on first The don't guidance. for to us. This

don't really any I So want specifically to go quarters. into

I evolving think as a way. that we're company,

to us said, kind and KPIs there. the as I we quarterly. still just to point investor the that walk But the think of get need still, to that - talk about track we will I But want I to run feeling year. want will very communicate good help before to appreciate front. we

Max Michaelis

guys. Thanks, right. All

Ed Stelmakh

thank you. Yeah,

Operator

Poppel from with question Our is Poppel. Please next Harvey proceed.

Harvey Poppel

in Well, Yeah, first very nice the hello. job quarter.

William Febbo

Thank you, Harvey.

Harvey Poppel

Quick question.

mention about facing least other talked higher the that sustained the the cost, your good at will terms that side at What are which to on which of be looks so You but from of didn't power, pricing many it does rate inflation, this all. And does What impact inflation of you companies, of end the like terms both is have business, year? the your of sign? negative impact a it? in headwinds

William Febbo

your have it operating But privately as not then fuel plans of, right I'll talk little Harvey. an or Yes. environment supply to already the of or most We people. facilities we're fuel. having pass and procurement and hear have I compensation this chain Great through bit, think in in Thanks, voice. we we lot place for do said, I'll just Ed. in to have or to baked need a ultimately, where a

Ed, already the anything... So clients little maybe I can you the such - on there. It's bit and pricing But speak P&L. it don't in to probably a see

Ed Stelmakh

Yeah.

who already long-term of round mean the from I you kind of the as recycles. to we're type be. will mean elected. But not definitely is a of of know, manage what most off positive mean labor-intensive expense which equation. highly business, right. what Just was side it knows the a increasing I impact is operating through I orbit

as far concerned, actually As us, a I tailwind. are clients for it's think

the of First increased because [ph] have power themselves of pharmas to arrangements all, nicely them inflation pricing into CPI. many baked pricing

for into percentage annual CPI increases extra a So points the obviously, budget gives their up, increases on they typically as them add goes few that commercial that them. and can

as bigger get us share the and wallet hopefully, So wallet growth continue the will of for to well.

Harvey Poppel

Thank Okay. you.

material sort is debt, no Board by the in stock high price over happened of two million given thinking $XX almost doing reaching what this to what's now cash possibility thirds the some buyback? the the with down point, stock from of of the of about question, the Second

Ed Stelmakh

mind, Yes. or all keep Obviously, team price. we shareholders. just the so look support my And at in stock

a any that it's have comprehensive any games. I we It's review that value going on to be you counterintuitive to and perform to the you business we're mean will the and it comment want don't to the off cash, to and So grow real in. shares is want take don't We discussion. I pretty have play to created. than use other think stage not

we everyone said, we'll that very However, being we though. at do obviously decide, when And options. it's valued, We always question, the look let we'll under as think those and appreciate know.

Harvey Poppel

very Okay. Thank you much.

Ed Stelmakh

well. Do Harvey. Thanks,

William Febbo

you. Thank

Operator

question Investor. next from Please Chez, is Our Private Ron proceed.

Unidentified Analyst

Good afternoon.

William Febbo

Hey, Ron. you? are How

Unidentified Analyst

Good job way. by the

William Febbo

Thank you.

Unidentified Analyst

not the Can grow welcome. You're to regard heard the leverage I You're revenue it likely operating some year? think be in leverage generate said expense going would I this operating I that what side confirm side? with that to to would proportion Ed that I thought

William Febbo

That's correct. Yes.

Unidentified Analyst

to you're you buy, about who going to interested you? in comes And asks to they're say everybody buying you what

William Febbo

balance in buying seen Yeah. with there few out acquisition, you've which obviously I spectacular people than Well, was right? last sheets, completed of late a it lot year We I year. just started inflation. slowed, think these macro things. big from an impact lot A this other And is early these everyone and think finished have would lot trends, of And particularly a they waiting. this that us, buyers possibly be larger do of a interested

they're math. And so I'm the doing all sure

And to and business, grow and be that be. it down will just the so what our will keep we're head going

Unidentified Analyst

agree in flexibility in opinion. retention now. general, right and personal with operating in cash of you are that mode a with I the the Just

William Febbo

Thank you.

Unidentified Analyst

have one I more question.

You're going are we I to - probably - going can't answer. to

acquisition, You're going support shareholder and Board to see of employees?

William Febbo

sign, in what just if can in we focused this business about that's Yeah. that we one future. about material, obviously a excited while no - the we it on it. it can good tell just see would I on for happens tough you, record, shares speaks business, sign. because one's are really really think be itself. very And And as always any the team and growing do on business very talk past, to keep a It to. would the to purchase, we'll It's a I get a the is have what positive be the just Again,

time known the huge. long me we mean, and the gotten level I'm and people excited things. on these conference is the this these the pretty I up. I about all - a need has that so me know business need. you've mean, and time days So long needs, really fired last few just at

keep So nice a we're build these to and to really to get going align business. big stars trying

Unidentified Analyst

luck. Good

William Febbo

Thanks, the support. appreciate I Ron.

Operator

session. turn We end of closing for like have over our reached management question-and-answer comments. the to the would conference I back to

William Febbo

closing I said tell were questions. realize focused We're part comments, things. we on I'll great that everyone. but the the what right those you, was Thanks, of

it's company. You've about heard a even the you're Everyone though the knows word team all technology people, a lot.

because we're on there. bigger they and And pace. can't start you lot, that. at they why I said the question are in, this think opportunity, big closer just really enough closer But very aren't cautious we're already? to and So as I we to Ron, it's our and - positive very lean go very, And once say we it's to get it's And own their a mainly business. getting a clients

everyone, So we to forward time, Operator? thanks, support, their for your to and QX. talking look you everyone, for cover to

Operator

conference. Thank you. This today's does conclude

for thank this may your you your lines time, and You at participation. disconnect

OptimizeRx (OPRX) 5 May 222022 Q1 Earnings call transcript